Serotonergic agonists and antagonists affect endurance performance in the rat

Area of Science:

• Exercise Physiology
• Neuropharmacology
• Behavioral Neuroscience

Background:

• Serotonin (5-HT) plays a crucial role in regulating various physiological functions, including motor activity and fatigue.
• Understanding the influence of serotonergic pathways on exercise performance is essential for developing targeted interventions.

Purpose of the Study:

• To investigate the effects of serotonergic (5-HT) agonist and antagonist drugs on exercise endurance in male and female rats.
• To determine if the observed effects are mediated by central or peripheral mechanisms.

Main Methods:

• Rats were administered quipazine dimaleate (a 5-HT agonist) or LY 53,857 (a 5-HT antagonist) prior to treadmill running.
• Run-time to exhaustion (RUN-EXH) was measured at a standardized intensity (20 m/min, 5% grade).
• The effects of a peripherally acting antagonist, xylamidine tosylate, were also assessed.

Main Results:

• Quipazine dimaleate dose-dependently reduced RUN-EXH in both male and female rats.
• LY 53,857 significantly increased RUN-EXH at the highest dose tested.
• The effects of the 5-HT agonist were not altered by the peripherally restricted antagonist, suggesting central mediation.

Conclusions:

• Pharmacological manipulation of serotonergic systems directly influences exercise fatigue.
• Central serotonergic mechanisms are likely involved in mediating the effects of these drugs on endurance.
• These findings provide insights into the neurobiological underpinnings of exercise performance and fatigue.